How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression

Before the pandemic forced remote work, school and research to the forefront, decentralized clinical trials were probably on the horizon. Now, they’re here in earnest.  This week, precision psychiatry startup Alto Neuroscience and Cerebral, an online mental health provider, announced that they’ve joined forces for a decentralized Phase 2 clinical trial for Alto Neuroscience’s depression … Continue reading How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression